MedTrace Logo

Multi-Center, Clinical Evaluation of the Cutera Secret RF Device

NCT03424161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2023-09-15

Study results available
· View outcomes & findings →

Summary

The objectives of this study are to evaluate the efficacy and safety of the Cutera Secret RF device.

Conditions

  • Skin Quality

Interventions

DEVICE

Secret RF

Subjects will receive treatment with the Secret RF device

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Ronan, MD · Cutera Research Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-10
Primary Completion
2018-10-08
Completion
2018-10-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03424161 on ClinicalTrials.gov